María Jesús
Monte Río
Catedrática de Universidad
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (26)
2024
-
Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition
Biochemical Pharmacology
-
New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 5
-
Relationship between cholestasis and altered progesterone metabolism in the placenta-maternal liver tandem
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 2
2022
-
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia
Hepatology, Vol. 76, Núm. 5, pp. 1259-1274
-
Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
Cancers, Vol. 14, Núm. 14
-
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation
Cells, Vol. 11, Núm. 24
-
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation
Journal of Hepatology, Vol. 77, Núm. 4, pp. 991-1004
2021
-
Gene supplementation of CYP27A1 in the liver restores bile acid metabolism in a mouse model of cerebrotendinous xanthomatosis
Molecular Therapy - Methods and Clinical Development, Vol. 22, pp. 210-221
-
Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics
Aging, Vol. 13, Núm. 19, pp. 23416-23434
-
STARD1 promotes NASH-driven HCC by sustaining the generation of bile acids through the alternative mitochondrial pathway
Journal of Hepatology, Vol. 74, Núm. 6, pp. 1429-1441
2020
-
Cellular mechanisms accounting for the refractoriness of colorectal carcinoma to pharmacological treatment
Cancers, Vol. 12, Núm. 9, pp. 1-34
-
Molecular bases of drug resistance in hepatocellular carcinoma
Cancers, Vol. 12, Núm. 6, pp. 1-26
-
Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: A machine-learning approach
Cancers, Vol. 12, Núm. 6, pp. 1-30
2019
-
Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy
Hepatology, Vol. 70, Núm. 4, pp. 1246-1261
-
Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps
Archives of Toxicology, Vol. 93, Núm. 3, pp. 623-634
-
The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis
Hepatology, Vol. 69, Núm. 4, pp. 1632-1647
2018
-
Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 9, pp. 2927-2937
2017
-
Lactation during cholestasis: Role of ABC proteins in bile acid traffic across the mammary gland
Scientific Reports, Vol. 7, Núm. 1
2016
-
Protective role of biliverdin against bile acid-induced oxidative stress in liver cells
Free Radical Biology and Medicine, Vol. 97, pp. 466-477
2014
-
Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development
Molecular Cancer Research, Vol. 12, Núm. 1, pp. 91-100